These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4548188)

  • 1. The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.
    Munchausen LL
    Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4519-22. PubMed ID: 4548188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of cis- and trans-dichlorodiammineplatinum(II) to the nucleosome core.
    Lippard SJ; Hoeschele JD
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6091-5. PubMed ID: 293706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of cis- and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix.
    Cohen GL; Bauer WR; Barton JK; Lippard SJ
    Science; 1979 Mar; 203(4384):1014-6. PubMed ID: 370979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of cis-dichlorodiammineplatinum(II).
    Zwelling LA; Kohn KW
    Cancer Treat Rep; 1979; 63(9-10):1439-44. PubMed ID: 387221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of DNA dynamics by platinum drug binding: a time-dependent fluorescence depolarization study of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA.
    Millar DP; Ho KM; Aroney MJ
    Biochemistry; 1988 Nov; 27(23):8599-606. PubMed ID: 3219364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscosity, nicking, thermal and alkaline denaturation studies on three classes of DNA-platinum complex.
    Butour JL; Macquet JP
    Biochim Biophys Acta; 1981 May; 653(3):305-15. PubMed ID: 7195737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic effects of some platinum co-ordination complexes on E.coli DNA as revealed by transformation studies.
    Hoekstra WP; Daemen CA; Otto ER
    Mutat Res; 1982 May; 94(1):53-62. PubMed ID: 7048087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
    Zaludová R; Natile G; Brabec V
    Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical studies on the binding of cis-dichlorodiamine platinum (II) to DNA and homopolynucleotides.
    Munchausen LL; Rahn RO
    Biochim Biophys Acta; 1975 Dec; 414(3):242-55. PubMed ID: 1203257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.
    Malfoy B; Hartmann B; Macquet JP; Leng M
    Cancer Res; 1981 Oct; 41(10):4127-31. PubMed ID: 7197193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
    Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
    Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.
    Poklar N; Pilch DS; Lippard SJ; Redding EA; Dunham SU; Breslauer KJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7606-11. PubMed ID: 8755522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evolution of cisplatin/DNA monoadducts into diadducts is dependent upon superhelical density.
    Bouayadi K; Calsou P; Pedrini AM; Salles B
    Biochem Biophys Res Commun; 1992 Nov; 189(1):111-8. PubMed ID: 1449466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of DNA binding of cis-platinum(II) antitumor drugs: a base sequence-dependent mechanism is proposed.
    Kelman AD; Peresie HJ
    Cancer Treat Rep; 1979; 63(9-10):1445-52. PubMed ID: 387222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis and ultraviolet inactivation of transforming DNA of Haemophilus influenzae complexed with a Bacillus subtilis protein that alters DNA conformation.
    Setlow JK; Setlow BC; Setlow P
    Acta Biochim Pol; 1996; 43(1):107-14. PubMed ID: 8790716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of DNA and purine nucleosides with cis-dichlorodiammineplatinum(II) and antimitotic activity of the complexes on meristematic root cells.
    De Pauw-Gillet MC; Houssier C; Fredericq E
    Chem Biol Interact; 1979 Apr; 25(1):87-102. PubMed ID: 466729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.